Addition of Dichlorocarbene on Organic Azides in Solid-Liquid Phase-Transfer Catalysis

DOI: 10.1016/S0040-4039(00)74205-5

Source and publish data:

Tetrahedron Letters p. 2339 - 2342 (1992)

Update date:2022-08-05

Topics:

Authors:

Szoenyi, F.

Cambon, A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(00)74205-5

The addition of dichlorocarbene on organic azides in homogeneous medium leads to isocyanide dihalides.In the conditions of the solid-liquid phase transfer catalysis, tetrachloroaziridines and isocyanide dihalides are obtained respectively as main products depending on whether a hydrogenated organic or whether a 2-F-alkylethyl azide is used. Key Words: Azides/ Dichlorocarbene/ Isocyanide dihalide/ Tetrachloroaziridine/ Phase-Transfer Catalysis.

Full text of DOI:10.1016/S0040-4039(00)74205-5

Products guided by the article

Product name:Aziridine, 2,2,3,3-tetrachloro-1-(phenylmethyl)-

Cas No:142030-36-2

R&D Labs maybe for 142030-36-2

Accendatech Co., LTD

Contact:+86-22-83718541

Address:32th Floor, Rongqiao Center Intersection of Changjiang Road and Nankai Six Road Nankai District Tianjin 300102, China
Binzhou Holly Pharmaceutical Co.,Ltd.

Contact:74517

Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Zhejiang Haizhou Pharmaceutical Co., Ltd.

website:https://www.haizhoupharma.com/

Contact:+86-576-88221016

Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Quzhou Aokai Chemical Co., Ltd.

Contact:86-570-3032832

Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Anhui Biochem United Pharmaceutical Co., Ltd.

Contact:0086 551 5167062 / 5228268

Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China

Relevant to this article

Furan-containing singlet oxygen-responsive conjugated polymers

Doi:10.1021/ma3025656
(2013)
Relative stereochemical determination and synthesis of the C17-C25 δ-lactone fragment of hemicalide

Doi:10.1021/jo302440a
(2013)
5-(3,4-dichlorophenyl)-3-{[4-(2-pyridyl)piperazine-1-yl]methyl}-1,3, 4-oxadiazole-2(3H)-one: Synthesis, characterization, X-ray and DFT structures

Doi:10.1134/S0022476612050162
(2012)
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor

Doi:10.1021/jm500973a
(2014)
Design, synthesis, antinociceptive and anti-inflammatory activities of novel piroxicam analogues

Doi:10.3390/molecules171214126
(2012)
Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones

Doi:10.3109/14756366.2013.873037
(2015)

Article Doi